November 15, 2021 10:44 AM Eastern Daylight Time

BUSINESS WIRE

Riassunto: BESREMi® (ropeginterferone alfa-2b) ottiene l'approvazione della FDA statunitense

Opens in new window

Download

Full Size JPEG, 550x128, 54.0 KB
Small JPEG, 480x112, 48.8 KB
Preview JPEG, 144x34, 23.3 KB
Thumbnail JPEG, 120x28, 21.6 KB

Smart Multimedia Gallery

Dr.  Rudolf Widmann Member of the Governing Board AOP Orphan International Copyright: Unkart

Dr.  Rudolf Widmann Member of the Governing Board AOP Orphan International Copyright: Unkart

View and Share Photo

http://www.businesswire.it/multimedia/it/20211115005957/it/5091703/

Share

Email

All News | News with Multimedia > Press Release: Riassunto: BESREMi® (ropeginterferone alfa-2b) ...